Related Experiment Videos
[Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
Dirk Sandner1, Lutz E Pillunat
1Klinik und Poliklinik für Augenheilkunde der Carl-Gustav-Carus-Universität Dresden. Dirk.Sandner@mailbox.tu-dresden.de
Klinische Monatsblatter Fur Augenheilkunde
|January 28, 2004
Summary
Interferon therapy can cause vision problems like blurred vision due to ischemic retinopathy. Discontinuing interferon treatment may reverse these ocular side effects, preventing vision loss.
Area of Science:
- Ophthalmology
- Hepatology
- Immunology
Background:
- Interferon therapy is crucial for treating viral and malignant diseases.
- Ocular complications, including retinal ischemia and arteriolar occlusion, are known adverse effects of interferon treatment.
- Early detection of visual changes is vital for managing interferon-related retinopathy.
Observation:
- A patient undergoing long-term interferon alpha therapy for chronic hepatitis B presented with blurred vision.
- Ophthalmic examination revealed incipient ischemic retinopathy with perimacular arteriolar alterations and cotton wool spots.
- Visual acuity and retinal findings improved significantly after discontinuing interferon therapy.
Findings:
- Blurred vision and dark spots can indicate early ischemic retinopathy in patients on long-term interferon therapy.
- Prompt cessation of interferon treatment can lead to reversible retinal alterations.
- Delayed diagnosis and continued interferon use may result in irreversible vision loss due to capillary non-perfusion and arteriolar occlusion.
Implications:
- Ophthalmologists should consider interferon-induced retinopathy in patients with unexplained visual complaints.
- Interdisciplinary consultation is recommended to weigh the benefits of interferon therapy against the risk of vision loss.
- Early intervention by discontinuing interferon therapy may preserve vision in affected patients.